로딩 중…
StockDiggingStockDigging

Evolent Health, Inc.

EVH· NYSE
$3.69+0.68%
2026-09-18

Financials

Valuation Metrics

Evolent Health, Inc.'s Market Cap is $416M. At end of 2025 it was $457M. Ranked #2861 of 3,121 in US market (top 92%), #1592 of 1,658 on NYSE (top 96%), #176 of 205 in Health Care Equipment & Services (top 86%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap$416M
Revenue$2.10B
Net Income$-505M
Total Assets$1.97B
Net Assets$383M
Employees4,200
Value
P/B1.08x
P/S0.20x
FCF Yield4.08%
Profitability
ROE-131.77%
ROA-25.61%
Op. Margin-1.37%
Revenue Growth-4.50%
Financial Health
Debt Ratio414.56%
Total Debt$970M
FCF$17M
Cash$116M
Current Ratio1.24x
Dividend
Div. Yield1.04%
Performance
1Y Return-57.72%
1M Return-19.32%
From 52W High-61.63%
1Y MDD-77.42%
Trading
Volume1,069,622 shares
Trading Value$4M
Per Share
EPS$-4.49
BPS$3.41

Company Info

CEO Seth Barrie Blackley
Employees 4,200
HQ Arlington, US

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.